Invention Grant
- Patent Title: Heteroaryl compounds useful as MK2 inhibitors
-
Application No.: US17477649Application Date: 2021-09-17
-
Publication No.: US11760763B2Publication Date: 2023-09-19
- Inventor: Jian Guo , John Malona , Alexander L. Ruchelman , Sekhar S. Surapaneni
- Applicant: Celgene CAR LLC
- Applicant Address: BM Pembroke
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agency: Choate, Hall & Stewart LLP
- Agent Kristen C. Buteau; Nicholas J. Pace
- The original application number of the division: US16494690
- Main IPC: C07D495/14
- IPC: C07D495/14 ; A61K31/551
Abstract:
The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
Public/Granted literature
- US20220064183A1 HETEROARYL COMPOUNDS USEFUL AS MK2 INHIBITORS Public/Granted day:2022-03-03
Information query
